Concepedia

Laure Vallotton

LV

Statistics

Publications

6

Citations

445

H-Index

6

Active since

2007

Affiliations

University Hospital of Lausanne(Current)

University of Lausanne

Polyclinic Medical University

Swiss Tropical and Public Health Institute

Laure Vallotton is an author at University Hospital of Lausanne specializing in vaccine development, medicine, and vaccine safety.

ORCID

Top concepts

Publications per year

2007–2018

6

Publications

6

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

François Spertini, R Audran, Reza Chakour et al. · The Lancet Respiratory Medicine · 2015 · 174 citations · Full text

, , +8

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Olga De Santis, R Audran, Emilie Pothin et al. · The Lancet Infectious Diseases · 2015 · 151 citations · Full text

, , +7

Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Rαhigh cell population in solid organ transplant recipients

Laura Codarri Deak, Laure Vallotton, Donatella Ciuffreda et al. · The Journal of Experimental Medicine · 2007 · 55 citations · Full text

The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers

Viviane Steiner-Monard, Kassim Kamaka, Olfa Karoui et al. · Clinical Infectious Diseases · 2018 · 33 citations · Full text

Monitoring of CD4+CD25highIL-7Rαhigh activated T Cells in Kidney Transplant Recipients

Laure Vallotton, Karine Hadaya, Jean-Pierre Venetz et al. · Clinical Journal of the American Society of Nephrology · 2011 · 19 citations · Full text

1–5 of 6